Test ministeriale in lingua inglese per l’ammissione alla facoltà di Medicina e Chirurgia 2013-2014
Any company that wishes to sell a new drug must provide the government with details of research about its safety and possible side effects. At present, this information is confidential, but there are plans to make it available to the public. While patients are surely entitled to more information about the drugs they are prescribed, this will also inevitably make public vital details about the ingredients of certain drugs and how they are manufactured. Drug companies are naturally reluctant to release this information to their competitors. Therefore, through fear of imitators, drug companies will no longer introduce new and important drugs into the country. Which one of the following, if true, would most weaken the above argument?